Mumbai-based HaystackAnalytics is making genomics accessible, applicable and affordable through a growing network of Genomics ...

Industrial robot programming AI agents from HD Hyundai Robotics and Palantir cut problem-resolution time 63 percent since ...

Tempus AI Inc. stocks have been trading up by 10.7 percent amid heightened optimism over its healthcare-focused AI innovations. Key Takeaways Multi‑year Bristol Myers Squibb agreement locks in ...

BillionToOne, Inc. is disrupting molecular diagnostics, leveraging proprietary smNGS technology for rapid growth and a $5.2B ...

Molecular and phylogenetic insights are essential for advancing diagnostics and vaccine development by providing ...

A structured narrative review argues that microbial signals detected on orthopaedic implants require a three-step ...

BriaCell Therapeutics is a clinical-stage biotechnology company developing targeted, off-the-shelf cellular immunotherapies ...

Pixelgen Technologies, Infiltrate Bio, and GATC Health are this year’s Top Innovations winners in the Emerging Startup ...

UAB experts said new bladder cancer, myeloma, and lung cancer therapies are changing care, but access and costs remain barriers.

What’s in a name? For a growing number of companies, it’s a chance to more closely associate their operations with the artificial intelligence boom. Some firms in the Chicago area have gone lengths to ...

The influx of novel therapies is expanding treatment options for patients with cancer, but distance, infrastructure, and ...

The patent cliff driving a wave of dealmaking is not new. What matters now is which assets stand out, and why some preclinical programs ...